在线日韩日本国产亚洲丨少妇伦子伦情品无吗丨欧美性猛交xxxx免费看蜜桃丨精品人妻系列无码一区二区三区丨亚洲精品无码不卡在线播放

Your Good Partner in Biology Research

IDH2 Antibody

  • 中文名稱:
    IDH2兔多克隆抗體
  • 貨號:
    CSB-PA148538
  • 規(guī)格:
    ¥1100
  • 圖片:
    • The image on the left is immunohistochemistry of paraffin-embedded Human cervical cancer tissue using CSB-PA148538(IDH2 Antibody) at dilution 1/60, on the right is treated with fusion protein. (Original magnification: ×200)
    • The image on the left is immunohistochemistry of paraffin-embedded Human colon cancer tissue using CSB-PA148538(IDH2 Antibody) at dilution 1/60, on the right is treated with fusion protein. (Original magnification: ×200)
    • Gel: 8%SDS-PAGE, Lysate: 40 μg, Lane 1-5: Human fetal muscle tissue, Jurkat cells, 293T cells, Hela cells, mouse liver tissue, Primary antibody: CSB-PA148538(IDH2 Antibody) at dilution 1/600, Secondary antibody: Goat anti rabbit IgG at 1/8000 dilution, Exposure time: 10 seconds
  • 其他:

產(chǎn)品詳情

  • Uniprot No.:
  • 基因名:
  • 別名:
    D2HGA2 antibody; ICD-M antibody; IDH antibody; IDH2 antibody; IDHM antibody; IDHP_HUMAN antibody; IDP antibody; IDPM antibody; Isocitrate dehydrogenase [NADP], mitochondrial antibody; Isocitrate dehydrogenase 2 (NADP+), mitochondrial antibody; mNADP-IDH antibody; NADP(+)-specific ICDH antibody; Oxalosuccinate decarboxylase antibody
  • 宿主:
    Rabbit
  • 反應(yīng)種屬:
    Human,Mouse,Rat
  • 免疫原:
    Fusion protein of Human IDH2
  • 免疫原種屬:
    Homo sapiens (Human)
  • 標記方式:
    Non-conjugated
  • 抗體亞型:
    IgG
  • 純化方式:
    Antigen affinity purification
  • 濃度:
    It differs from different batches. Please contact us to confirm it.
  • 保存緩沖液:
    -20°C, pH7.4 PBS, 0.05% NaN3, 40% Glycerol
  • 產(chǎn)品提供形式:
    Liquid
  • 應(yīng)用范圍:
    ELISA,WB,IHC
  • 推薦稀釋比:
    Application Recommended Dilution
    ELISA 1:2000-1:5000
    WB 1:500-1:2000
    IHC 1:100-1:300
  • Protocols:
  • 儲存條件:
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • 貨期:
    Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
  • 用途:
    For Research Use Only. Not for use in diagnostic or therapeutic procedures.

產(chǎn)品評價

靶點詳情

  • 功能:
    Plays a role in intermediary metabolism and energy production. It may tightly associate or interact with the pyruvate dehydrogenase complex.
  • 基因功能參考文獻:
    1. pharmacogenetics: observations uncover a mechanism of acquired resistance to a targeted therapy and underscore the importance of 2-hydroxyglutarate production in the pathogenesis of IDH2-mutant malignancies PMID: 29950729
    2. We validated the presence of IDH2 R172 hotspot mutations and PIK3CA hotspot mutations in 100% and 67% of solid papillary breast carcinoma with reverse polarity tested, respectively PMID: 29603332
    3. Enasidenib reduces 2-hydroxyglutarate levels in patients with relapsed or refractory (R/R) acute myeloid leukemia harboring either IDH2-R140 or IDH2-R172 mutations PMID: 29243965
    4. IDH2 mutation is associated with glioma progression. PMID: 29016871
    5. This study furthers implementation of clinical genomics in MDS and identifies TP53 and IDH2 as targets for pre- or post-transplant therapy PMID: 28687222
    6. IDH2(mut) patients had a higher risk of leukemic transformation. The co-occurrence of DNMT3A or SRSF2 mutations was found to be increased in IDH2(mut) patients. IDH2 mutations were associated with significantly worse OS and LFS amongst patients with low-risk MDS by IPSS grouping. PMID: 29549529
    7. IDH2 R172 mutations may be the only variants present in angioimmunoblastic T-cell lymphoma because of their capacity to produce significant amounts of the oncometabolite 2-hydroxyglutarate in the cell of origin of this disease PMID: 27956631
    8. IDH2 mutation is associated with 1p19q co-deletion diffuse glioma. PMID: 28340142
    9. data confirm MLL-PTD and, to a lesser extent, FLT3-ITD as common events in +11 AML.6, 7, 8 However, the high mutation frequencies of U2AF1 and genes involved in methylation (DNMT3A, IDH2) have hitherto not been reported in +11 AML PMID: 27435003
    10. We demonstrate that the majority of histologically defined sinonasal undifferentiated carcinomas are characterized by IDH2 R172X mutations and overexpression of mutant protein PMID: 28084339
    11. The found of this study that IDH12 mutation status had greater impact than histological and other genomic features on miRNA expression patterns. PMID: 28091987
    12. demonstrate the presence of the IDH2 p.R172K/S mutation in patients with cutaneous localizations of angioimmunoblastic T-cell lymphomas. PMID: 28945625
    13. IDH2 mutation is associated with high-grade gliomas. PMID: 27353503
    14. these results suggest a potential relationship between SIRT3 enzymatic activity, IDH2-K413 acetylation-determined dimerization, and a cancer-permissive phenotype PMID: 28536275
    15. There are frequent IDH2 R172 mutations in undifferentiated and poorly-differentiated sinonasal carcinomas. PMID: 28493366
    16. Results identified IDH2 rs11540478 as a new susceptibility locus for lung cancer. PMID: 27649069
    17. Functional studies demonstrated that IDH2 and PIK3CA hotspot mutations are likely drivers of solid papillary carcinoma with reverse polarity PMID: 27913435
    18. IDH2 mutation is associated with polycythemia vera and essential thrombocythemia. PMID: 27997717
    19. Mutations in some enzymes of the TCA cycle: Isocitrate dehydrogenase (IDH), succinate dehydrogenase (SDH) and fumarate hydratase (FH) are associated with the accumulation of metabolites that are able to influence many aspects of cancer development and progression and for this reason are termed onco-metabolites. PMID: 27528759
    20. Only three IDH2(R172) mutation cases were detected in this series of patients with astrocytomas and oligodendrogliomas PMID: 27780605
    21. these data suggest that IDH2 may be a tumor suppressor in that its loss may promote malignant progression of gastric cancer via NF-kappaB-dependent increases in MMP7 activity. PMID: 26553362
    22. Genetic variants in IDH2 were found in patients with hematological malignancies. PMID: 27591990
    23. CASP8 rs3769823 and IDH2 rs4561444 were as the potential functional variants in high-linkage disequilibrium with these single nucleotide polymorphisms, respectively. The IDH2 mRNA levels were down-regulated in oesophageal squamous cell carcinoma. PMID: 26635288
    24. Results revealed that the expression of IDH2 was inversely correlated with pathological grade and metastasis in osteosarcoma and its downregulation may exacerbate malignant progression via increased NF-kappaB and MMP-9 activity. PMID: 26782630
    25. mechanistic studies of IDH2 mutations in gliomas (review) PMID: 26188014
    26. IDH2 mutation is associated with higher risk of malignant transformation in low-grade glioma. PMID: 26780338
    27. Results show that IDH2 is hypermethylated in glioma and the mutations are mutually exclusive with PTEN, P53 and ATRX mutations in the tumors. PMID: 27245697
    28. The Isocitrate dehydrogenase is mutated at a key active site arginine residue (Arg172 in IDH2) in many cancers, leading to the synthesis of the oncometabolite (R)-2-hydroxyglutarate (2HG). PMID: 26761588
    29. Down regulation of IDH2 may promote HCC cell invasion via NF-x03BA;B-dependent increases in MMP9 activity. IDH2 may be a potential therapeutic target for HCC PMID: 26646705
    30. With the advent of large-scale genome sequencing technology, molecular genetic alterations in IDH2 promoter have now been identified in the majority of oligodendrogliomas PMID: 26545048
    31. IDH2 mutations and their functions in human tumors (review) PMID: 26147657
    32. Glioblastomas with IDH1-m should be considered a different entity from the IDH1-wt, as their natural history and prognosis differ. In the near future we should be classified glioblastomas based on the presence of the IDH1 mutation PMID: 26194445
    33. The IDH2 mutations are associated with improved survival in patients with Glioblastomas. PMID: 26945349
    34. IDH2 mutation produced more 2-HG than IDH1 mutation. PMID: 26669865
    35. Authors suggest 2HG as an analytic marker (in serum, urine, or biopsies) predicting malignancy of breast cancer in all patients. PMID: 26007236
    36. report of clinicopathological characteristics of the gliomas with IDH2 mutations including two cases of primary GBM carrying a novel missense IDH2 mutation (c. 484C>T, p. P162S) PMID: 25495392
    37. suggest that mutations in isocitrate dehydrogenases IDH1/2 lead to a local block in osteogenic differentiation during skeletogenesis causing the development of benign cartilaginous tumors. PMID: 26046462
    38. IDH2 mutations are associated with normal cytogenetics and type A NPM1 mutations in Acute Myeloid Leukaemia. PMID: 25987093
    39. IDH2R172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphoma. PMID: 26268241
    40. IDH2 mutation is associated with response to therapy in anaplastic astrocytoma. PMID: 24993250
    41. IDH2 mutations are associated with myelodysplastic syndromes. PMID: 24936872
    42. IDH2 gene SNPs exhibited significant association with death risk in hepatocellular carcinoma patients. PMID: 25355558
    43. A review summarizes the function of mutated vs. wild-type IDH enzymes and the role of IDH2 mutations in gliomas. PMID: 25078896
    44. Gliomas were classified into five principal groups on the basis of three tumor markers including IDH2. The groups had different ages at onset, overall survival, and associations with germline variants. PMID: 26061753
    45. Isocitrate dehydrogenase 2 mutation is associated with infiltrative glioma. PMID: 24860178
    46. When normalized with the respective WT-IDH cells, the general metabolic shifts of MT-IDH1 and IDH2 were almost opposite. Lactate level was lower in MT-IDH2 cells which produced more 2-HG than MT-IDH1 cells. PMID: 25251602
    47. we propose the TCM compounds, precatorine and abrine, as potential candidates as lead compounds for further study in drug development process with the IDH2 R140Q mutant protein against cancer PMID: 24995286
    48. These results indicated lithium chloride could decrease the proliferation and migration potential of C6 glioma cells harboring IDH2 mutation. PMID: 24549719
    49. The recent discoveries reported here help understanding of the role of the IDH1/2 mutations in chondrosarcomas. IDH mutational status serves as a molecular signature to differentiate chondrosarcomas from other sarcomas with cartilaginous element. PMID: 24867810
    50. knowledge of the IDH mutation status has had significant translational implications, and diagnostic tools are being used to monitor its expression and function[Review] PMID: 23373447

    顯示更多

    收起更多

  • 相關(guān)疾病:
    D-2-hydroxyglutaric aciduria 2 (D2HGA2); Glioma (GLM)
  • 亞細胞定位:
    Mitochondrion.
  • 蛋白家族:
    Isocitrate and isopropylmalate dehydrogenases family
  • 數(shù)據(jù)庫鏈接:

    HGNC: 5383

    OMIM: 137800

    KEGG: hsa:3418

    STRING: 9606.ENSP00000331897

    UniGene: Hs.596461



主站蜘蛛池模板: 国产成人久久精品流白浆| 亚洲精品久久久一区| 国产精品无码午夜福利| 九色porny丨自拍视频| 色狠狠成人综合网| 99久久久无码国产精品免费| 四房播色综合久久婷婷| 国产拍揄自揄免费观看| 亚洲男女一区二区三区| 成人做爰69片免费看网站野花| 亚洲精品无码不卡av| 无码熟妇人妻av在线影片最多| 欧美又大又色又爽aaaa片| 欧美色偷偷亚洲天堂bt| 好紧好爽免费午夜视频| 2019一級特黃色毛片免費看| 少妇高潮毛片免费看| 亚洲精品乱码久久久久红杏| 久久精品国产久精国产果冻传媒| 亚洲第一狼人伊人av| 久久久久国色av免费看| 在线日韩日本国产亚洲| 日韩制服国产精品一区| 色五月丁香六月欧美综合| av色综合久久天堂av色综合在| 成年午夜精品久久久精品| 超碰97人人让你爽| 亚洲成av人片在www色猫咪| 国产婷婷色一区二区三区在线| 久久久774这里只有精品17| 欧美精品人人做人人爱视频| 一本精品中文字幕在线| 日韩人妻熟女中文字幕aⅴ春菜| 久久免费精品国产72精品九九 | 色琪琪av中文字幕一区二区| 中文字幕亚洲欧美日韩在线不卡| 亚洲国产精品一区第二页| 国产在线第一区二区三区| 日产精品久久久久久久| 国产亚洲精品久久久久久| 精品久久国产综合婷婷五月|